Journal Information
Vol. 16. Issue 5.
Pages 815-828 (September - October 2010)
Share
Share
Download PDF
More article options
Vol. 16. Issue 5.
Pages 815-828 (September - October 2010)
Artigo de Revisão/Review Article
Open Access
Complicações pulmonares não infecciosas após transplante de células-tronco hematopoiéticas
Non-infectious pulmonary complications after the hematoppoietic stem cell trasplantation
Visits
5212
Eliane Viana Mancuzo1, Marina Augusto Neves2, Henrique Bittencourt3, Nilton Alves de Rezende1,
Corresponding author
narezende@terra.com.br

Correspondência: Professor Nilton Alves de Rezende, Departamento de Clinica Medica, Faculdade de Medicina da UFMG, Avenida Alfredo Balena 190, CEP-30130-100, Belo Horizonte, Brasil.
1 Serviço de Pneumologia, Hospital das Clinicas, Universidade Federal de Minas Gerais, Brasil
2 Acadêmica da Faculdade de Medicina da Universidade Federal de Minas Gerais, Brasil
3 Unidade de Transplante de Medula Óssea, Hospital das Clinicas, Universidade Federal de Minas Gerais, Brasil.
This item has received

Under a Creative Commons license
Article information
Resumo

As complicações pulmonares constituem importante causa de morbidade e mortalidade após o transplante de células-tronco hematopoiéticas (TCTH) ocorrendo em cerca de 30 a 60% dos receptores. O avanço na profilaxia e tratamento de complicações infecciosas tem aumentado de forma significativa a parcela de complicações pulmonares não infecciosas. O diagnóstico e o tratamento precoce destas complicações podem mudar o prognóstico dos receptores de transplante de células-tronco hematopoéticas. O objectivo deste estudo é rever as principais complicações não infecciosas associadas ao TCTH desde a realização do primeiro transplante de medula óssea em 1957.

Foi realizada uma revisão sistemática da literatura utilizando-se a estratégia PICO para a construção das perguntas. Os descritores transplante de células-tronco hematopoiéticas, complicações pulmonares não infecciosas, revisão sistemática, em português e seus correspondentes em inglês, foram utilizados para acesso às seguintes bases de dados: MEDLINE, EBM, EMBASE, COCRANE LIBRARY, LILACS e SciELO. Nesta revisão foram identificados 263 trabalhos. Destes, 30 foram seleccionados para serem analisados na íntegra. As complicações pulmonares não infecciosas mais frequentemente descritas foram: bronquiolite obliterante, bronquiolite obliterante com pneumonia em organização, edema pulmonar, síndroma da pneumonia idiopática, síndroma da toxicidade pulmonar por droga, hemorragia alveolar difusa, síndroma do enxerto e trombo citolítico pulmonar.

Rev Port Pneumol 2010; XVI (5): 815-828

Palavras-chave:
Transplante de células-tronco hematopoiéticas
complicações pulmonares não infecciosas
revisão sistemática
Abstract

Pulmonary complications are important cause of mortality and morbidity after hematopoietic stem cell transplantation, in 30% to 60% of the patients. Improvements in prophylaxis and treatment of infectious complications have been increasing the rate of non-infectious complications. Early diagnosis and treatment of those complications can significantly change the evolution of hematopoietic stem cell transplantation receptors.

The objective of this study is to review the most frequent non-infection complications associated to hematopoietic stem cell transplantation since the first bone marrow transplantation performed in 1957.

A systematic literature review was performed, using the PICO strategy to ask the questions. The descriptors hematopoietic stem cell transplantation, non-infectious pulmonary complications, systematic review, in portuguese and their english correspondents, were used to access the following databases: MEDLINE, EBM, Embase, Cocrane Library, LILACS and SciELO. In this review, 263 studies were identified, from which 31 were selected for full analyzis.

The non-infection pulmonary complications most frequently found were: bronchiolitis obliterans, bronchiolitis obliterans organizing pneumonia, pulmonary edema, idiopathic pneumonia syndrome, delayed pulmonary toxicity syndrome, diffuse alveolar hemorrhage, engrafment syndrome and pulmonary cytolitic thrombi.

Rev Port Pneumol 2010; XVI (5): 815-828

Key-words:
Hematopoietic stem cell transplantation
non-infectious pulmonary complications
systematic review
Full text is only aviable in PDF
Bibliografia
[1.]
B. Afessa, S.G. Peters.
Chronic lung disease after hematopoietic stem cell transplantation.
Clin Chest Med, 26 (2005), pp. 571-586
[2.]
K. Sirithanakul, A. Salloum, J.L. Klein, A.O. Soubani.
Pulmonary complications following hematopoietic stem cell transplantation: diagnostic approaches.
Am J Hematol, 80 (2005), pp. 137-146
[3.]
A.O. Soubani, J.P. Uberti.
Bronchiolitis obliterans following haematopoietic stem cell transplantation.
Euro Respir J, 29 (2007), pp. 1007-1019
[4.]
D.L. Coy, A. Ormazabal, J.D. Godwin, T. Lalani.
Imaging evaluation of pulmonary and abdominal complications following hematopoietic stem cell transplantation.
Radiographics, 25 (2005), pp. 305-317
[5.]
M. Ditschkowski, A.H. Elmaagacli, R. Trenschel, R. Peceny, M. Koldehoff, C. Schulte, D.W. Beelen.
T-cell depletion prevents from bronchiolitis obliterans and bronchiolitis obliterans with organizing pneumonia after allogeneic hematopoietic stem cell transplantation with related donors.
Haematológica, 92 (2007), pp. 558-561
[6.]
A.H. Filipovich, D. Weisdorf, S. Pavletic, et al.
National Institutes of health consensus development project oncriteria for clinical trials in chronic graft-versus-hostdisease: I. Diagnosis and staging working group report.
Biol Blood Marrow Transplant, 11 (2005), pp. 945-956
[7.]
J.D. Rizzo, J.R. Wingard, A. Tichelli, et al.
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation.
Biology of Blood and Marrow Transplantation, 12 (2006), pp. 138-151
[8.]
E.V. Mancuso, N.A. Rezende.
Pulmonary function testing in bone marrow transplantation: a systematic review.
Rev Port Pneumol, 12 (2006), pp. 61-69
[9.]
R.M. Kotloff, V.N. Ahya, S.W. Crawford.
Pulmonary complications of Solid Organ and Hematopoietic Stem Cell Transplantation.
Am J Resp Crit Care Med, 170 (2004), pp. 22-48
[10.]
B. Afessa, M.R. Litzow, A. Tefferi.
Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation.
Bone Marrow Transplant, 28 (2001), pp. 425-434
[11.]
F. Patriarca, C. Skert, F. Bonifazi, A. Sperotto, C. Fili, M. Stanzani, F. Zaja, M. Cerno, A. Geromin, G. Bandini, M. Baccarani, R. Fanin.
Effect on survival of the development of late-onset non-infectious pulmonary complications after stem cell transplantation.
Haematologica, 91 (2006), pp. 1268-1272
[12.]
J.W. Chien, D.K. Mates, J.G. Clark.
Pulmonary function testing prior to hematopoiéticas stem cell transplantation.
Bone Marrow Transplant, 35 (2005), pp. 429-435
[13.]
H. Lim do, J. Lee, H.G. Lee, B.B. Park, K.R. Peck, W.S. Oh, S.H. Ji, S.H. Lee, J.O. Park, K. Kim, W.S. Kim, C.W. Jung, Y.S. Park, Y.H. Im, W.K. Kang, K. Park.
Pulmonary complications after hematopoietic stem cell transplantation.
J Korean Med Sci, 21 (2006), pp. 406-411
[14.]
C.M.C. Santos, C.A.M. Pimenta, M.R.C. Nobre.
The PICO strategy for the research question construction and evidence search.
Rev Latino-Am Enfermagem, 15 (2007), pp. 508-511
[15.]
S.G. Peters, B. Afessa.
Acute lung injury after hematopoietic stem cell transplantation.
Clin Chest Med, 26 (2005), pp. 561-569
[16.]
W.E. Beschorner, R. Saral, G.M. Hutchins, P.J. Tutschka, G.W. Santos.
Lymphocytic bronchitis associated with graft-versus-host disease in recipients of bone-marrowtransplants.
N Engl J Med, 299 (1978), pp. 1030-1036
[17.]
J.W. Chien, P.J. Martin, T.A. Gooley, et al.
Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation.
Am J Respir Crit Care Med, 168 (2003), pp. 208-214
[18.]
H.L. Paz, P. Crilley, A. Patchefsky, R.L. Schiffman, I. Brodsky.
Bronchiolitis obliterans after autologous bone marrow transplantation.
Chest, 101 (1992), pp. 775-778
[19.]
J. Frankovich, S.S. Donaldson, Y. Lee, R.M. Wong, M. Amylon, M.R. Verneris.
High-dose therapy and autologous hematopoietic cell transplantation in children with primary refractory and relapsed Hodgkin’s disease: atopy predicts idiopathic diffuse lung injury syndromes.
Biol Blood Marrow Transplant, 7 (2001), pp. 49-57
[20.]
L.H.S. Tomas, F.R. Loberiza, J.P. Klein, P.M. Layde, R.J. Lipchik, J.D. Rizzo, C.N. Bredeson, M.M. Horowitz.
Risk factors for bronquiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia.
Chest, 128 (2005), pp. 153-161
[21.]
J.W. Chien, P.J. Martin, M.E. Flowers, W.G. Nichols, J.G. Clark.
Implications of early airflow decline after my eloablative allogeneic stem cell transplantation.
Bone Marrow Transplant, 33 (2004), pp. 759-764
[22.]
T.K. Marras, C.K. Chan, J.H. Lipton, H.A. Messner, J.P. Szalai, A. Laupacis.
Long-term pulmonary function abnormalities and survival after allogenic marrow transplantation.
Bone Marrow Transplant, 33 (2004), pp. 509-517
[23.]
D.J. Curtis, A. Smale, F. Thien, et al.
Chronic airflow obstruction in long-term survivors of allogeneic bone marrow transplantation.
Bone Marrow Transplant, 16 (1995), pp. 169-173
[24.]
J.G. Clark, S.W. Crawford, D.K. Madtes, K.M. Sullivan.
Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course.
Ann Intern Med, 111 (1989), pp. 368-376
[25.]
J.G. Clark, D.A. Schwartz, N. Flournoy.
Risk factors for airflow obstruction in recipients of bone marrow transplants.
Ann Intern Med, 107 (1987), pp. 648-656
[26.]
S.O. Wanko, G. Broadwater, R.J. Folz, N.J. Chao.
Diffuse alveolar hemorrhage: retrospective review of clinical outcome in allogeneic transplant recipients treated with aminocaproic acid.
Biol Blood Marrow Transplant, 12 (2006), pp. 949-953
[27.]
S. Yoshihara, U. Tateishi, T. Ando, et al.
Lower incidence of bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning.
Bone Marrow Transplant, 35 (2005), pp. 1195-1200
[28.]
A. Panoskaltsis-Mortari, K.V. Tram, A.P. Price, C.H. Wendt, B.R. Blazar.
A new murine model for bronchiolitisobliterans post-bone marrow transplant.
Am J Respir Crit Care Med, 176 (2007), pp. 713-723
[29.]
K.R. Schultz, G.J. Green, D. Wensley, et al.
Obstructive lung disease in children after allogeneic bone marrow transplantation.
Blood, 84 (1994), pp. 3212-3220
[30.]
A. Palmas, A. Tefferi, J.L. Myers, et al.
Late-onset noinfectious pulmonary complications after allogeneic bone marrow transplantation.
Br J Haemotol, 100 (1998), pp. 680-687
[31.]
K. Alasy, N. Muller, D.N. Ostrrow, et al.
Cryptogenic organizing pneumonia. A report of 25 cases and a review of literature.
Medicine, 74 (1995), pp. 201-211
[32.]
T. Fukuda, R.C. Hackman, K.A. Guthrie, B.M. Sandmaier, M. Boeckh, M.B. Maris, D.G. Maloney, H.J. Deeg, P.J. Martin, R.F. Storb, et al.
Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative compared to conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation.
Blood, 102 (2003), pp. 2777-2785
[33.]
R.A. Robbins, J. Linder, M.G. Stahl, A.B. Thompson III, W. Haire, A. Kessinger, J.O. Armitage, M. Arneson, G. Woods, W.P. Vaughan, et al.
Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients.
Am J Med, 87 (1989), pp. 511-518
[34.]
B. Afessa, A. Tefferi, M.R. Litzow, M.J. Krowka, M.E. Wylam, S.G. Peters.
Diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients.
Am J Respir Crit Care Med, 166 (2002), pp. 641-645
[35.]
J.R. Wingard, E.D. Mellits, R.J. Jones, et al.
Association of hepatic veno-occlusive disease with interstitial pneumonitis in bone marrow transplant recipients.
Bone Marrow Transplant, 4 (1989), pp. 685-689
[36.]
M.C. Bunte, M.M. Patnaik, M.R. Pritzker, L.J. Burns.
Pulmonary veno-occlusive disease following hematopoietic stem cell transplantation: a rare model of endothelial dysfunction.
Bone Marrow Transplantation, 41 (2008), pp. 677-686
[37.]
L.M. Williams, S. Fussell, R.W. Veith, et al.
Pulmonary veno-occlusive disease in an adult following bone marrow trasnplntation.
Case report and review of the literature. Chest, 109 (1996), pp. 1388-1391
[38.]
J. Mandel, E.J. Mark, C.A. Hales.
Pulmonary veno-occlusive disease.
Am J Respir Crit Care Med, 162 (2000), pp. 1964-1973
[39.]
S.J. Stevens, E.A. Verschuuren, S.A. Verkuujlen, A.J. Van Den Brule, C.J. Meijer, J.M. Middeldorp.
Role of Epstein–Barr virus DNA load monitoring in prevention and early detection of post-transplant lymphoproliferative disease.
Leuk Lymphoma, 43 (2002), pp. 831-840
[40.]
M. Benkerrou, J.P. Jais, V. Leblond, A. Durandy, L. Sutton, P. Bordigoni, et al.
Anti-B-cell monoclonal antibody treatment of severe post-transplant B-lymphoproliferative disorder: prognostic factors and long-term outcome.
Blood, 92 (1998), pp. 3137-3147
[41.]
H. Kage, T. Kohyama, H. Kitagwa, D. Takai, Y. Kanda.
Non-infeccious bronchiolitis as an early pulmonary complications of hematopoietic stem cell transplantation.
Intern Med, 47 (2008), pp. 61-64
[42.]
T.R. Spitzer.
Engraftment syndrome following hematopoietic stem cell transplantation.
Bone Marrow Transplant, 27 (2001), pp. 893-898
[43.]
S.W. Wilczynski, J.J. Erasmus, W.P. Petros, J.J. Vredenburgh, R.J. Folz.
Delayed pulmonary toxicity syndrome following high-dose chemotherapy and bone marrow transplantation for breast cancer.
Am J Respir Crit Care Med, 157 (1998), pp. 565-573
[44.]
P. Pedrazzoli, P. Ferrante, A. Kulekci, et al.
Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) Registry 1990-1999.
Bone Marrow Transplantation, 32 (2003), pp. 489-494
[45.]
L. Chap, R. Shpiner, M. Levine, et al.
Pulmonary toxicity of high-dose chemotherapy for breast cancer: a non-invasive approach to diagnosis and treatment.
Bone Marrow Transplant, 20 (1997), pp. 1063-1067
[46.]
A.A. Castellano-Sanchez, R.J. Poppiti.
Pulmonry cytolytic thrombi (PCT). A previously unrecognized complication of bone marrow transplantation (BMT).
Am J Surg Pathol, 25 (2001), pp. 829-831
[47.]
I.J. Morales, P.M. Anderson, H.D. Tazelaar, et al.
Pulmonary cytolytic thrombi: unsual complication of bone marrow transplantation.
J Pediatr Hematol Oncol, 25 (2003), pp. 89-92
[48.]
J.P. Woodard, H.E. Gulbahce, M. Shreve, et al.
Pulmonary cytolytic thrombi: a newly recognized complication of stem cell transplantation.
Bone Marrow Transplant, 25 (2000), pp. 293-300
[49.]
H.E. Gulbahce, J.C. Manivel, J. Jessurun.
Pulmonary cytolytic thrombi: a previously unrecognized complication of bone marrow transplantation.
Am J Surg Pathol, 24 (2000), pp. 1147-1152
[50.]
R.E. Curtis, L.B. Travis, P.A. Rowlings, G. Socie, D.W. Kingma, P.M. Banks, et al.
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study.
Blood, 94 (1999), pp. 2208-2216
[51.]
K. Carlson, L. Backlund, B. Smedmyr, G. Oberg, B. Simonsson.
Pulmonary function and complications subsequent to autologous bone marrow transplantation.
Bone Marrow Transplantation, 14 (1994), pp. 805-811
[52.]
R. Ghalie, J.P. Szidon, L. Thompson, Y.N. Nawas, A. Dolce, H. Kaizer.
Evaluation of pulmonary complications after bone marrow transplantation: the role of pretransplant pulmonary function tests.
Bone Marrow Transplantation, 10 (1992), pp. 359-365
Copyright © 2010. Sociedade Portuguesa de Pneumologia/SPP
Pulmonology
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?